ENTRY       D10453                      Drug
NAME        Bezlotoxumab (USAN/INN);
            Bezlotoxumab (genetical recombination) (JAN);
            Zinplava (TN)
  ABBR      BEZ
PRODUCT     ZINPLAVA (Merck Sharp & Dohme LLC)
FORMULA     C6464H9974N1726O2014S46
EXACT_MASS  145473.8259
MOL_WEIGHT  145563.7042
SEQUENCE    (Heavy chain)
            EVQLVQSGAE VKKSGESLKI SCKGSGYSFT SYWIGWVRQM PGKGLEWMGI FYPGDSSTRY
            SPSFQGQVTI SADKSVNTAY LQWSSLKASD TAMYYCARRR NWGNAFDIWG QGTMVTVSSA
            STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG
            LYSLSSVVTV PSSSLGTQTY ICNVNHKPSN TKVDKRVEPK SCDKTHTCPP CPAPELLGGP
            SVFLFPPKPK DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYNS
            TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV YTLPPSREEM
            TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS KLTVDKSRWQ
            QGNVFSCSVM HEALHNHYTQ KSLSLSPGK
            (Light chain)
            EIVLTQSPGT LSLSPGERAT LSCRASQSVS SSYLAWYQQK PGQAPRLLIY GASSRATGIP
            DRFSGSGSGT DFTLTISRLE PEDFAVYYCQ QYGSSTWTFG QGTKVEIKRT VAAPSVFIFP
            PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS QESVTEQDSK DSTYSLSSTL
            TLSKADYEKH KVYACEVTHQ GLSSPVTKSF NRGEC
            (Disulfide bridge: H22-H96, H146-H202, H222-L215, H228-H'228, H231-H'231, H263-H323, H369-H427, H'22-H'96, H'146-H'202, H'222-L'215, H'263-H'323, H'369-H'427, L23-L89, L135-L195, L'23-L'89, L'135-L'195)
  TYPE      Peptide
REMARK      Therapeutic category: 6399
            ATC code: J06BC03
            Product: D10453<JP/US>
EFFICACY    Antibacterial, Antitoxin
  DISEASE   Clostridium difficile infection [DS:H00338]
  TYPE      Monoclonal antibody
COMMENT     Prevention of recurrence of Clostridium difficile infection (CDI)
TARGET      Clostridioides difficile toxin B [KO:K11063]
  PATHWAY   ko02024(K11063)  Quorum sensing
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J06 IMMUNE SERA AND IMMUNOGLOBULINS
               J06B IMMUNOGLOBULINS
                J06BC Antibacterial monoclonal antibodies
                 J06BC03 Bezlotoxumab
                  D10453  Bezlotoxumab (USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Gastrointestinal Agents
              Gastrointestinal Agents, Other
               Bezlotoxumab
                D10453  Bezlotoxumab (USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              63  Biological preparations
               639  Miscellaneous
                6399  Others
                 D10453  Bezlotoxumab (USAN/INN); Bezlotoxumab (genetical recombination) (JAN)
            Antimicrobials [BR:br08307]
             Antibacterials
              Other antibacterials
               Monoclonal antibody
                D10453  Bezlotoxumab (USAN/INN) &lt;JP/US&gt;
            Antimicrobials abbreviations [BR:br08327]
             Antibacterials
              Other antibacterials
               Monoclonal antibody
                D10453  Bezlotoxumab (USAN/INN)
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10453
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10453
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D10453
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10453
DBLINKS     CAS: 1246264-45-8
            PubChem: 172232546
///
